The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Lilly(Eli) & Co (NYSE: LLY) closed the day trading at $820.1 down -0.76% from the previous closing price of $826.41. In other words, the price has decreased by -$0.76 from its previous closing price. On the day, 2.49 million shares were traded. LLY stock price reached its highest trading level at $829.4599 during the session, while it also had its lowest trading level at $814.053.
Ratios:
For a better understanding of LLY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 218.89 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 158.90. For the most recent quarter (mrq), Quick Ratio is recorded 1.00 and its Current Ratio is at 1.28. In the meantime, Its Debt-to-Equity ratio is 2.18 whereas as Long-Term Debt/Eq ratio is at 1.87.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on October 20, 2025, Reiterated its Outperform rating but revised its target price to $930 from $840 previously.
Berenberg Downgraded its Buy to Hold on September 17, 2025, while the target price for the stock was maintained at $830.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 10 ’25 when LILLY ENDOWMENT INC sold 3,658 shares for $863.24 per share. The transaction valued at 3,157,722 led to the insider holds 94,533,320 shares of the business.
LILLY ENDOWMENT INC sold 10,602 shares of LLY for $9,038,055 on Oct 09 ’25. The 10% Owner now owns 94,536,978 shares after completing the transaction at $852.49 per share. On Oct 10 ’25, another insider, LILLY ENDOWMENT INC, who serves as the 10% Owner of the company, bought 305,000 shares for $855.35 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LLY now has a Market Capitalization of 735184158720 and an Enterprise Value of 772744216576. As of this moment, Lilly(Eli)’s Price-to-Earnings (P/E) ratio for their current fiscal year is 54.38, and their Forward P/E ratio for the next fiscal year is 27.11. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.31. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.57 while its Price-to-Book (P/B) ratio in mrq is 42.49. Its current Enterprise Value per Revenue stands at 14.509 whereas that against EBITDA is 31.19.
Stock Price History:
The Beta on a monthly basis for LLY is 0.42, which has changed by -0.024113476 over the last 52 weeks, in comparison to a change of 0.18258524 over the same period for the S&P500. Over the past 52 weeks, LLY has reached a high of $935.62, while it has fallen to a 52-week low of $623.78. The 50-Day Moving Average of the stock is 6.17%, while the 200-Day Moving Average is calculated to be 4.11%.
Shares Statistics:
Over the past 3-months, LLY traded about 4.53M shares per day on average, while over the past 10 days, LLY traded about 2480880 shares per day. A total of 946.83M shares are outstanding, with a floating share count of 849.83M. Insiders hold about 10.21% of the company’s shares, while institutions hold 73.51% stake in the company. Shares short for LLY as of 1760486400 were 6843231 with a Short Ratio of 1.51, compared to 1757894400 on 7323001. Therefore, it implies a Short% of Shares Outstanding of 6843231 and a Short% of Float of 0.86.
Dividends & Splits
LLY’s forward annual dividend rate is 5.80, up from 5.6 a year ago. Against a Trailing Annual Dividend Yield of 0.0067762975. The stock’s 5-year Average Dividend Yield is 1.04. The current Payout Ratio is 44.39% for LLY, which recently paid a dividend on 2025-08-15 with an ex-dividend date of 2025-11-14. Stock splits for the company last occurred on 1997-10-16 when the company split stock in a 2:1 ratio.
Earnings Estimates
Its stock is currently analyzed by 19.0 different market analysts. The consensus estimate for the next quarter is $6.92, with high estimates of $8.17 and low estimates of $6.4.
Analysts are recommending an EPS of between $25.03 and $21.43 for the fiscal current year, implying an average EPS of $22.51. EPS for the following year is $30.48, with 25.0 analysts recommending between $35.69 and $26.2.
Revenue Estimates
20 analysts predict $16.07B in revenue for. The current quarter. It ranges from a high estimate of $16.43B to a low estimate of $15.41B. As of. The current estimate, Lilly(Eli) & Co’s year-ago sales were $11.44BFor the next quarter, 20 analysts are estimating revenue of $17.29B. There is a high estimate of $17.61B for the next quarter, whereas the lowest estimate is $16.68B.
A total of 27 analysts have provided revenue estimates for LLY’s current fiscal year. The highest revenue estimate was $63.43B, while the lowest revenue estimate was $60.3B, resulting in an average revenue estimate of $61.66B. In the same quarter a year ago, actual revenue was $45.04BBased on 27 analysts’ estimates, the company’s revenue will be $73.31B in the next fiscal year. The high estimate is $79.01B and the low estimate is $67.01B.
